SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-041471
Filing Date
2018-06-21
Accepted
2018-06-21 09:18:50
Documents
3
Period of Report
2018-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-12086_68k.htm 8-K 34499
2 EX-99.1 a18-12086_6ex99d1.htm EX-99.1 8621
3 GRAPHIC g120866mmi001.jpg GRAPHIC 6582
  Complete submission text file 0001104659-18-041471.txt   53656
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 18911029
SIC: 3841 Surgical & Medical Instruments & Apparatus